JP2010518007A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518007A5
JP2010518007A5 JP2009548329A JP2009548329A JP2010518007A5 JP 2010518007 A5 JP2010518007 A5 JP 2010518007A5 JP 2009548329 A JP2009548329 A JP 2009548329A JP 2009548329 A JP2009548329 A JP 2009548329A JP 2010518007 A5 JP2010518007 A5 JP 2010518007A5
Authority
JP
Japan
Prior art keywords
seq
composition
polypeptide
sema6a
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518007A (ja
JP5492567B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/001444 external-priority patent/WO2008097503A2/en
Publication of JP2010518007A publication Critical patent/JP2010518007A/ja
Publication of JP2010518007A5 publication Critical patent/JP2010518007A5/ja
Application granted granted Critical
Publication of JP5492567B2 publication Critical patent/JP5492567B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548329A 2007-02-02 2008-02-04 髄鞘形成およびオリゴデンドロサイト分化を促進するためのセマフォリン6aの使用 Active JP5492567B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89899207P 2007-02-02 2007-02-02
US60/898,992 2007-02-02
PCT/US2008/001444 WO2008097503A2 (en) 2007-02-02 2008-02-04 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation

Publications (3)

Publication Number Publication Date
JP2010518007A JP2010518007A (ja) 2010-05-27
JP2010518007A5 true JP2010518007A5 (cg-RX-API-DMAC7.html) 2011-03-24
JP5492567B2 JP5492567B2 (ja) 2014-05-14

Family

ID=39682299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548329A Active JP5492567B2 (ja) 2007-02-02 2008-02-04 髄鞘形成およびオリゴデンドロサイト分化を促進するためのセマフォリン6aの使用

Country Status (17)

Country Link
US (1) US9107884B2 (cg-RX-API-DMAC7.html)
EP (1) EP2114433B1 (cg-RX-API-DMAC7.html)
JP (1) JP5492567B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090123873A (cg-RX-API-DMAC7.html)
CN (1) CN101631559A (cg-RX-API-DMAC7.html)
AU (1) AU2008214337B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0806849A2 (cg-RX-API-DMAC7.html)
CA (1) CA2677228C (cg-RX-API-DMAC7.html)
EA (1) EA017403B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20135853B (cg-RX-API-DMAC7.html)
IL (1) IL200123A (cg-RX-API-DMAC7.html)
MX (1) MX2009008178A (cg-RX-API-DMAC7.html)
NZ (1) NZ578816A (cg-RX-API-DMAC7.html)
SG (1) SG178744A1 (cg-RX-API-DMAC7.html)
UA (1) UA99452C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008097503A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200905379B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871205B2 (en) * 2009-11-25 2014-10-28 The University Of North Carolina At Chapel Hill Methods and compositions for the treatment of immune disorders
FI3590960T3 (fi) * 2012-02-29 2023-04-25 Takeda Pharmaceuticals Co Perifeeristen hermojen IgG-stimuloitu remyelinaatio
EP3215191B1 (en) 2014-11-05 2024-08-14 Voyager Therapeutics, Inc. Aadc polynucleotides for the treatment of parkinson's disease
KR20230145206A (ko) 2014-11-14 2023-10-17 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
CN114717264A (zh) 2014-11-14 2022-07-08 沃雅戈治疗公司 治疗肌萎缩性侧索硬化(als)的组合物和方法
EP3262064A1 (en) * 2015-02-23 2018-01-03 Seagull Therapeutics SAS Non-natural semaphorins 3 and their medical use
ES2969187T3 (es) * 2015-06-29 2024-05-16 Univ British Columbia Tratamientos, métodos y usos de la proteína de fusión B1SP
US10584337B2 (en) 2016-05-18 2020-03-10 Voyager Therapeutics, Inc. Modulatory polynucleotides
JP7109040B2 (ja) * 2016-07-25 2022-07-29 国立大学法人金沢大学 線維化抑制剤
EP3618839A4 (en) 2017-05-05 2021-06-09 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CN112424359A (zh) 2018-05-15 2021-02-26 沃雅戈治疗公司 用于治疗帕金森氏病的组合物和方法
CN109536506B (zh) * 2018-12-10 2022-03-22 潍坊科技学院 一种调控日本沼虾生长发育的类胰岛素受体基因及其应用
WO2025105734A1 (ko) * 2023-11-15 2025-05-22 주식회사 카인사이언스 탈수초 질환 치료용 펩타이드 및 이의 용도

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773319A (en) 1971-12-16 1973-11-20 Fabcor Ind Inc Corrugated sheet inverting machine
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3572982D1 (en) 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
GB2183662B (en) 1985-04-01 1989-01-25 Celltech Ltd Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
ES2150428T3 (es) 1987-04-27 2000-12-01 Unilever Nv Ensayos de union especifica.
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5336603A (en) 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
GB8809129D0 (en) 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells
WO1989012624A2 (en) 1988-06-14 1989-12-28 Cetus Corporation Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
EP0401384B1 (en) 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
IE63847B1 (en) 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
DE69127749T2 (de) 1990-03-20 1998-04-16 The Trustees Of Columbia University In The City Of New York, New York, N.Y. Chimäre antikörper mit rezeptor-bindenden liganden anstelle ihrer konstanten region
US5219837A (en) * 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
ATE218889T1 (de) 1990-11-09 2002-06-15 Stephen D Gillies Cytokine immunokonjugate
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
CA2149326C (en) 1992-11-13 2007-04-17 Mitchell E. Reff Fully impaired consensus kozak sequences for mammalian expression
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
RO120148B1 (ro) 1997-03-14 2005-09-30 Idec Pharmaceuticals Corporation Sistem vector şi procedeu de inserţie a unui fragment adn, în genomul celulelor de mamifere
EP1365018A1 (en) 2002-05-23 2003-11-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) CD100 semaphorin in myelination
CA2487939A1 (en) * 2002-05-30 2003-12-11 Curagen Corporation Semaphorin-like proteins and methods of using same

Similar Documents

Publication Publication Date Title
JP2009544703A5 (cg-RX-API-DMAC7.html)
US20240010708A1 (en) Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
JP2011500566A5 (cg-RX-API-DMAC7.html)
US6531295B1 (en) Synthetic constructs encoding syndecan
JP2021193112A (ja) 生物学的に活性な特異的カーゴペプチドと結合したヒト由来の細胞透過性ペプチドの構造、製造および使用
JP5492567B2 (ja) 髄鞘形成およびオリゴデンドロサイト分化を促進するためのセマフォリン6aの使用
JP2006507228A (ja) 応答性の細胞、組織および器官を保護、回復ならびに増強するための組換え型組織保護サイトカインおよびそれをコードする核酸
Beerens et al. Protein transduction domains and their utility in gene therapy
JP2007511232A5 (cg-RX-API-DMAC7.html)
CN104650210B (zh) 作为体内造血刺激剂的tat‑hoxb4h重组蛋白质的制备方法
US6800286B1 (en) Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
JP2017082008A (ja) 血清アミロイドp誘導体並びに同誘導体の製造及び使用
EP2406281B1 (en) Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
NZ568705A (en) Methods for promoting neurite outgrowth and survival of dopaminergic neurons
JP2009518299A5 (cg-RX-API-DMAC7.html)
CZ295997A3 (cs) Způsob kultivace buněk
JP2009538282A5 (cg-RX-API-DMAC7.html)
CN1339068A (zh) 转移核酸通过核被膜的细胞转运系统的用途
EP3263582B1 (en) Polymer compound which has membrane-permeable peptide in side chain
WO2024054062A1 (ko) 세포 내 형질주입을 위한 신규한 폴리펩타이드 조성물
JP2004515534A (ja) 生存を促進するncam結合化合物およびncamリガンド結合化合物
CN101384622A (zh) Fgf2结合肽及其用途
US20210115089A1 (en) Antitumor peptide and use thereof
WO2023229366A1 (en) Surface-engineered extracellular vesicles and therapeutic uses thereof
KR20260011856A (ko) Kkkk 돌연변이 adamts1 펩타이드 및 이를 포함하는 근육 질환 치료용 약제학적 조성물